Atherosclerosis
Volume 146, Issue 1 , Pages 153-160 , September 1999

Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations

  • Robert A Hegele

      Affiliations

    • Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, Department of Medicine, 406-100 Perth Drive, London, Ont., N6A 5K8, Canada
    • Corresponding Author InformationCorresponding author. Tel.: +1-519-6633461; fax: +1-519-6633789
    • ,
  • Stewart B Harris

      Affiliations

    • Thames Valley Family Practice Research Unit, University of Western Ontario, London, Ont., Canada
    • ,
  • J Howard Brunt

      Affiliations

    • School of Nursing, University of Victoria, Victoria, BC, Canada
    • ,
  • T Kue Young

      Affiliations

    • Northern Health Research Unit, Department of Community Health Sciences, University of Manitoba, Winnipeg, Man., Canada
    • ,
  • Anthony J.G Hanley

      Affiliations

    • Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ont., Canada
    • ,
  • Bernard Zinman

      Affiliations

    • Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ont., Canada
    • Department of Medicine, University of Toronto, Toronto, Ont., Canada
    • ,
  • Philip W Connelly

      Affiliations

    • St. Michael’s Hospital, Toronto, Ont., Canada
    • Department of Medicine, University of Toronto, Toronto, Ont., Canada
    • Department of Biochemistry, University of Toronto, Toronto, Ont., Canada

Received 27 July 1998 ,Revised 17 February 1999 ,Accepted 23 February 1999.

References 

  1. Goldstein JL, Brown MS. The clinical investigator: bewitched, bothered, and bewildered—but still beloved. J Clin Invest. 1997;99:2803–2812
  2. Mehrabian M, Lusis AJ. Genetic markers for atherosclerosis and related risk factors. In:  Lusis AJ,  Rotter JI,  Sparkes RS editor. Molecular Genetics of Coronary Artery Disease: Candidate Genes and Processes in Atherosclerosis. Basel: Karger; 1992;p. 363–418
  3. Hegele RA. Candidate genes, small effects, and the prediction of atherosclerosis. Crit Rev Clin Lab Sci. 1997;34:343–367
  4. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037–2048
  5. Murtomaki S, Tahvanainen E, Antikainen M, Tiret L, Nicaud V, Jansen H, Ehnholm C. Hepatic lipase gene polymorphisms influence plasma HDL levels. Arterioscler Thromb Vasc Biol 1997;1879–1884.
  6. Guerra R, Wang J, Grundy SM, Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA. 1997;94:4532–4537
  7. Jansen H, Verhoeven AJM, Weeks L, Kastelein JJP, Halley DJJ, van den Ouweland A, et al. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol. 1997;17:2837–2842
  8. Tahvanainen E, Syvanne M, Frick MH, Murtomaki-Repo S, Antikainen M, Kesaniemi YA, et al. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Investigators. J Clin Invest. 1998;101:956–960
  9. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC. Hepatic lipase activity is lower in African American men than in white American men: effects of the 5′ flanking polymorphism in the hepatic lipase gene. J Lipid Res. 1998;39:228–232
  10. Cai SJ, Wong DM, Chen SH, Chan L. Structure of the human hepatic triglyceride lipase gene. Biochemistry. 1989;28:8966–8971
  11. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the angiotensinogen gene is associated with variation in blood pressure in a genetic isolate. Circulation. 1994;90:2207–2212
  12. Hegele RA, Evans AJ, Tu L, Ip G, Brunt JH, Connelly PW. A gene-gender interaction affecting lipoproteins in a genetic isolate. Arterioscler Thromb. 1994;14:671–678
  13. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. Arterioscler Thromb Vasc Biol. 1995;15:89–95
  14. Hegele RA, Brunt JH, Connelly PW. Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites. Arterioscler Thromb Vasc Biol. 1995;15:861–871
  15. Hegele RA, Brunt JH, Connelly PW. Genetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation. 1995;92:1089–1093
  16. Hegele RA, Breckenridge WC, Brunt JH, Connelly PW. Genetic variation in factor VII associated with variation in plasma lipoprotein (a) concentration. Arterioscler Thromb Vasc Biol. 1997;17:1701–1706
  17. Hegele RA, Brunt JH, Connelly PW. Genetic and biochemical factors associated with variation in blood pressure in a genetic isolate. Hypertension. 1996;27:308–312
  18. Harris SB, Gittelsohn J, Hanley AJG, Barnie A, Wolever TMS, Gao J, et al. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care. 1997;20:185–197
  19. Hegele RA, Harris SB, Hanley AJ, Sadikian S, Connelly PW, Zinman B. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab. 1996;81:4334–4337
  20. Hegele RA, Connelly PW, Scherer SW, Hanley AJ, Harris SB, Tsui LC, et al. Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1997;82:3373–3377
  21. Hegele RA, Connelly PW, Scherer SW, Hanley AJ, Harris SB, Tsui LC, et al. Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes. Lancet. 1997;350:785
  22. Hegele RA, Zinman B, Hanley AJ, Harris S, Connelly PW. A common mtDNA polymorphism associated with variation in plasma triglyceride concentration. Am J Hum Genet. 1997;60:1552–1555
  23. Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arterioscler Thromb Vasc Biol. 1997;17:1060–1066
  24. Hegele RA, Harris SB, Hanley AJ, Sun F, Connelly PW, Zinman B. Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension. 1997;29:1073–1077
  25. Hegele RA, Young TK, Connelly PW. Are Canadian Inuit at increased genetic risk for coronary heart disease?. J Mol Med. 1997;75:364–370
  26. Hegele RA, Tully C, Young TK, Connelly PW. V677 mutation of methylene-tetrahydrofolate reductase and cardiovascular disease in Canadian Inuit. Lancet. 1997;349:1221–1222
  27. SAS/STAT Guide for personal computers. SAS Institute, Cary, NC, 1987.
  28. Hegele RA, Little JA, Vezina C, Maguire G, Tu L, Wolever TMS, et al. Hepatic lipase deficiency: clinical, biochemical and molecular genetic characteristics. Arterioscler Thromb Vasc Biol. 1993;13:720–728
  29. Hegele RA, Breckenridge WC, Cox DW, Maguire GF, Little JA, Connelly PW. Elevated low density lipoprotein triglyceride concentrations in subjects heterozygous for hepatic lipase S267F variant. Arterioscler Thromb Vasc Biol. 1998;18:1212–1216
  30. Knudsen P, Antikainen M, Ehnholm S, Uusi-Oukari M, Tenkanen H, Lahdenpera S, et al. A compound heterozygote for hepatic lipase gene mutations Leu334->Phe and Thr383->Met: correlation between hepatic lipase activity and phenotypic expression. J Lipid Res. 1996;37:825–834
  31. Knudsen P, Antikainen M, Uusi-Oukari M, Ehnholm S, Lahdenpera S, Bensadoun A, et al. Heterozygous hepatic lipase deficiency due to two missense mutations R186H and L334F in the HL gene. Atherosclerosis. 1997;128:165–174
  32. Brand K, Dugi KA, Brunzell JD, Nevin DN, Santamarina-Fojo S. A novel A->G mutation of intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. J Lipid Res. 1996;37:1213–1223
  33. Howard BV, Pan XR, Harper I, Kuusi T, Taskinen MR. Lack of sex differences in high density lipoproteins in Pima Indians. Studies of obesity, lipase activities, and steroid hormones. Artherosclerosis. 1987;7:292–300
  34. Reitman JS, Kosmakos FC, Howard BV, Taskinen MR, Kuusi T, Nikkila EA. Characterization of lipase activities in obese Pima indians. Decreases with weight reduction. J Clin Invest. 1982;70:791–797
  35. Zambon A, Deeb SS, Hokanson JE, Brown BG, Brunzell JD. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol. 1998;18:1723–1729
  36. Nie L, Wang J, Clark LT, Tang A, Vega GL, Grundy SM, et al. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res. 1998;39:1127–1130

PII: S0021-9150(99)00113-6

Atherosclerosis
Volume 146, Issue 1 , Pages 153-160 , September 1999

Article Tools